IBRN holdings

All 81 positions of iShares Neuroscience and Healthcare ETF.

Download CSV

Positions

Top 10 weight

41.1%

Effective holdings

35.3

1 / sum of squared weights

In stocks

99.8%

In bonds

0.0%

Outside the US

24.6%

Asset mix

Equity99.8%
Cash0.2%

Sectors

83% of stocks classified

Health Care80.0%
Materials2.4%

Countries

United States75.2%
Belgium3.9%
South Korea3.3%
Sweden3.1%
Denmark2.9%
Australia2.4%
Japan2.1%
Switzerland2.0%
China1.7%
India1.3%
France1.0%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	BIIBBiogen Inc. Common Stock	Equity	4.86%	$305K	1,396	US
2	EWTXEdgewise Therapeutics, Inc. Common Stock	Equity	4.47%	$280K	7,148	US
3	NBIXNeurocrine Biosciences Inc	Equity	4.46%	$280K	1,981	US
4	PTCTPTC Therapeutics, Inc.	Equity	4.43%	$278K	4,446	US
5	ALKSAlkermes Inc. plc	Equity	4.27%	$268K	6,686	US
6	ARGXargenx SE American Depositary Shares	Equity	3.90%	$245K	299	BE
7	SRRKScholar Rock Holding Corporation Common Stock	Equity	3.74%	$235K	5,565	US
8	DNTHDianthus Therapeutics, Inc. Common Stock	Equity	3.74%	$235K	2,848	US
9	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	3.67%	$231K	875	US
10	SUPNSupernus Pharmaceuticals, Inc.	Equity	3.56%	$223K	5,299	US
11	ACADAcadia Pharmaceuticals Inc.	Equity	3.43%	$215K	10,995	US
12	DYNDyne Therapeutics, Inc. Common Stock	Equity	3.31%	$208K	12,682	US
13	SK BIOPHARMACEUTICALS LTD	Equity	3.30%	$207K	3,810	KR
14	XENEXenon Pharmaceuticals Inc	Equity	2.97%	$187K	5,158	US
15	AXGNAxogen, Inc. Common Stock	Equity	2.94%	$184K	5,092	US
16	H. LUNDBECK CLASS B	Equity	2.87%	$180K	26,061	DK
17	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	2.85%	$179K	9,823	US
18	NEUNewMarket Corporation	Equity	2.40%	$151K	10,697	AU
19	BHVNBiohaven Ltd.	Equity	2.38%	$149K	12,496	US
20	BIOARCTIC CLASS B	Equity	1.93%	$121K	4,158	SE
21	TSHATaysha Gene Therapies, Inc. Common Stock	Equity	1.81%	$114K	25,694	US
22	ONCOLYS BIOPHARMA INC	Equity	1.55%	$97K	2,500	JP
23	LBRXLB Pharmaceuticals Inc Common Stock	Equity	1.42%	$89K	2,568	US
24	IDIAIDORSIA N LTD	Equity	1.41%	$89K	18,238	CH
25	IARTIntegra LifeSciences Holdings	Equity	1.38%	$87K	6,460	US
26	RAPPRapport Therapeutics, Inc. Common Stock	Equity	1.33%	$83K	2,790	US
27	ANROAlto Neuroscience Inc.	Equity	1.32%	$83K	3,451	US
28	RUBICONRUBICON RESEARCH	Equity	1.27%	$80K	5,020	IN
29	DYVOXDYNAVOX GROUP	Equity	1.22%	$76K	9,662	SE
30	APMDApnimed, Inc. Common Stock	Equity	1.09%	$69K	3,765	US
31	MEDCLMEDINCELL SA	Equity	1.02%	$64K	2,299	FR
32	ANNXAnnexon, Inc. Common Stock	Equity	1.01%	$64K	15,907	US
33	CBLLCeriBell, Inc. Common Stock	Equity	0.92%	$58K	2,492	US
34	SLDBSolid Biosciences Inc. Common Stock	Equity	0.90%	$56K	8,282	US
35	METIS TECHBIO CLASS H	Equity	0.78%	$49K	24,500	CN
36	OVIDOvid Therapeutics Inc. Common Stock	Equity	0.66%	$41K	17,646	US
37	CAPRCapricor Therapeutics Inc	Equity	0.66%	$41K	5,151	US
38	BWAYBrainsway Ltd. American Depositary Shares	Equity	0.65%	$41K	3,577	IL
39	NGNENeurogene, Inc. Common Stock	Equity	0.64%	$40K	1,525	US
40	DRUGBright Minds Biosciences Inc. Common Stock	Equity	0.61%	$38K	739	US
41	DSGNDesign Therapeutics, Inc. Common Stock	Equity	0.61%	$38K	3,311	US
42	PRTAProthena Corporation plc Ordinary Shares	Equity	0.60%	$38K	4,406	US
43	ZYLOX-TONBRIDGE MEDICAL TECH H	Equity	0.54%	$34K	13,000	CN
44	NPCENeuropace, Inc. Common Stock	Equity	0.52%	$33K	2,649	US
45	SANBIO LTD	Equity	0.51%	$32K	5,800	JP
46	BNTCBenitec Biopharma Inc. Common Stock	Equity	0.46%	$29K	3,291	US
47	CLPTClearPoint Neuro, Inc. Common Stock	Equity	0.44%	$28K	2,652	US
48	MICROPORT NEUROTECH CORP	Equity	0.41%	$26K	25,000	CN
49	VNDAVanda Pharmaceuticals Inc.	Equity	0.41%	$25K	5,617	US
50	ABEOAbeona Therapeutics Inc. Common Stock	Equity	0.39%	$25K	4,984	US
51	KYTXKyverna Therapeutics, Inc. Common Stock	Equity	0.37%	$23K	3,780	US
52	SANNSANTHERA N AG	Equity	0.35%	$22K	1,311	CH
53	ALECAlector, Inc. Common Stock	Equity	0.26%	$16K	8,058	US
54	NWRNNEWRON PHARMACEUTICALS	Equity	0.24%	$15K	1,724	CH
55	NGENNervGen Pharma Corp. Common stock	Equity	0.23%	$14K	8,257	CA
56	PEPGPepGen Inc. Common Stock	Equity	0.23%	$14K	6,067	US
57	AVXLAnavex Life Sciences	Equity	0.22%	$14K	8,919	US
58	CAMPCAMP4 Therapeutics Corporation Common Stock	Equity	0.21%	$13K	3,492	US
59	TRDAEntrada Therapeutics, Inc. Common Stock	Equity	0.20%	$13K	2,324	US
60	ABOSAcumen Pharmaceuticals, Inc. Common Stock	Equity	0.20%	$13K	6,065	US
61	LRMRLarimar Therapeutics, Inc. Common Stock	Equity	0.20%	$13K	4,716	US
62	TNXPTonix Pharmaceuticals Holding Corp.	Equity	0.19%	$12K	1,679	US
63	VYGRVoyager Therapeutics, Inc. Common Stock	Equity	0.19%	$12K	5,059	US
64	NERVMinerva Neurosciences, Inc	Equity	0.19%	$12K	3,670	US
65	MOBIMobia Medical, Inc. Common Stock	Equity	0.17%	$11K	1,252	US
66	MPLTMapLight Therapeutics, Inc. Common Stock	Equity	0.16%	$10K	1,127	US
67	XTSLABLK CSH FND TREASURY SL AGENCY	Cash	0.13%	$8K	7,954	US
68	CGTXCognition Therapeutics, Inc. Common Stock	Equity	0.12%	$8K	8,501	US
69	NMRANeumora Therapeutics, Inc. Common Stock	Equity	0.06%	$4K	7,567	US
70	SGAFTCASH COLLATERAL USD SGAFT	Cash	0.03%	$2K	2,000	US
71	AUDAUD CASH	Cash	0.02%	$1K	1,451	AU
72	KRWKRW CASH	Cash	0.02%	$968	1,295,819	KR
73	JPYLazard Japanese Equity ETF	Cash	0.01%	$933	147,628	JP
74	EUREUR CASH	Cash	0.01%	$492	439	EU
75	CHFCHF CASH	Cash	0.00%	$287	239	CH
76	DKKDKK CASH	Cash	0.00%	$270	1,801	DK
77	HKDAMTD Digital Inc. American Depositary Shares (every five of which represent two Class A Ordinary Shares)	Cash	0.00%	$253	1,989	HK
78	SEKSEK CASH	Cash	0.00%	$110	1,100	SE
79	HWRZ6MICRO E-MINI RUSSELL 2000 DEC 26	Derivative	0.00%	$0	1
80	ETD USD BALANCE WITH R30382	Cash	-0.00%	−$13	-13	US
81	USDProShares Ultra Semiconductors	Cash	-0.06%	−$4K	-3,820	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
New position	ARWRARROWHEAD PHARMACEUTICALS, INC.	—	4.41%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	AVDLAVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY	2.64%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	PRAXPraxis Precision Medicines Inc	5.02%	3.66%	−14.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	XENEXenon Pharmaceuticals Inc	3.61%	4.79%	+15.0%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ANROAlto Neuroscience Inc	—	0.78%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	FULCFulcrum Therapeutics Inc	0.68%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	LBRXLB Pharmaceuticals Inc	—	0.63%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	CAPRCapricor Therapeutics Inc	1.15%	1.75%	+17.0%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	RLMDRelmada Therapeutics Inc	—	0.48%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	DSGNDesign Therapeutics Inc	—	0.46%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	MPLTMapLight Therapeutics Inc	—	0.42%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	BHVNBiohaven Ltd	1.68%	1.30%	+13.3%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	Newron Pharmaceuticals SpA	—	0.35%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	OVIDOVID THERAPEUTICS INC.	—	0.34%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	Zylox-Tonbridge Medical Technology Co Ltd	0.81%	0.51%	−19.3%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	Santhera Pharmaceuticals Holding AG	—	0.28%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	NBIXNEUROCRINE BIOSCIENCES, INC.	3.47%	3.68%	+30.1%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ACIUAC Immune SA	—	0.20%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	IKTInhibikase Therapeutics Inc	—	0.19%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	SGMOQSANGAMO THERAPEUTICS, INC.	0.23%	0.05%	+13.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	PTCTPTC THERAPEUTICS, INC.	3.88%	3.69%	+31.2%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	Myung In Pharm Co Ltd	—	0.16%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	NMRANeumora Therapeutics Inc	—	0.15%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	DRUGBright Minds Biosciences Inc	0.80%	0.92%	+20.8%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ABOSAcumen Pharmaceuticals Inc	—	0.12%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	PEPGPepGen Inc	—	0.11%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	DYNDyne Therapeutics, Inc	2.46%	2.36%	+15.9%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	BrainAurora Medical Technology Ltd	—	0.09%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	Oncolys Biopharma Inc	0.41%	0.49%	−12.8%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	GANXGain Therapeutics Inc	—	0.07%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	LRMRLarimar Therapeutics Inc	0.24%	0.18%	−23.1%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	NGNENEUROGENE INC.	0.31%	0.34%	−11.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	FLNAFilana Therapeutics, Inc	0.10%	0.07%	+12.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ACADACADIA PHARMACEUTICALS INC.	3.63%	3.61%	+32.1%	Jan 31, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.